Dual Ribosome Profiling uncovers metabolic vulnerabilities in the Tumor Microenvironment of Triple Negative Breast Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Heidelberg, Universität Heidelberg, Dissertation, 2023
- Keyword
-
Krebs
Breast Cancer
Metabolism
Ribosome Profiling
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (who)
-
Universitätsbibliothek Heidelberg
- (when)
-
2023
- Creator
-
Aviles Huerta, Daniela
- Contributor
-
Wiemann, Stefan
- DOI
-
10.11588/heidok.00033886
- URN
-
urn:nbn:de:bsz:16-heidok-338864
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aviles Huerta, Daniela
- Wiemann, Stefan
- Universitätsbibliothek Heidelberg
Time of origin
- 2023
Other Objects (12)
Integrate and conquer: pan-cancer proteogenomics uncovers cancer vulnerabilities and therapeutic opportunities
Comparative ribosome profiling uncovers a dominant role for translational control in Toxoplasma gondii
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Vulnerabilities
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities
Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
Tumor microenvironment and immunotherapy for triple-negative breast cancer
The ribosome
Integrate and conquer: pan-cancer proteogenomics uncovers cancer vulnerabilities and therapeutic opportunities
Comparative ribosome profiling uncovers a dominant role for translational control in Toxoplasma gondii
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Vulnerabilities
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities
Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
Tumor microenvironment and immunotherapy for triple-negative breast cancer
The ribosome
Integrate and conquer: pan-cancer proteogenomics uncovers cancer vulnerabilities and therapeutic opportunities
Comparative ribosome profiling uncovers a dominant role for translational control in Toxoplasma gondii
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Vulnerabilities
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities
Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
Tumor microenvironment and immunotherapy for triple-negative breast cancer